Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifemd Inc 8.875% Series A (LFMDP)

Lifemd Inc 8.875% Series A (LFMDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Reports Third Quarter 2025 Results

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30%...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications,...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD to Participate in the BTIG Digital Health Forum

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced the sale of its majority ownership interest...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD to Report Third Quarter 2025 Financial Results on November 6

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and nine...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Tara Scott, MD, widely known as “...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LFMD Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Securities Fraud Class Action Against LifeMD, Inc.

SAN DIEGO , Oct. 1, 2025 /PRNewswire/ -- Robbins LLP  reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD,...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk...

LFMDP : 21.35 (+1.86%)
LFMD : 3.20 (-0.93%)

Barchart Exclusives

Is This Soon-to-Be $1 Trillion Stock a Buy Now?
The world’s biggest retailer is playing offense again. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar